Globus Medical Inc (NYSE: GMED) is 56.86% higher on its value in year-to-date trading and has touched a low of $44.02 and a high of $84.87 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The GMED stock was last observed hovering at around $83.32 in the last trading session, with the day’s gains setting it 0.27%.
Currently trading at $83.59, the stock is 6.24% and 12.71% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.04 million and changing 0.32% at the moment leaves the stock 28.56% off its SMA200. GMED registered 84.20% gain for a year compared to 6-month gain of 24.48%. The firm has a 50-day simple moving average (SMA 50) of $73.8768 and a 200-day simple moving average (SMA200) of $64.86605.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 13.99% loss in the last 1 month and extending the period to 3 months gives it a 19.96%, and is 1.27% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.21% over the week and 2.17% over the month.
Globus Medical Inc (GMED) has around 5000 employees, a market worth around $11.38B and $2.48B in sales. Current P/E ratio is 126.10 and Fwd P/E is 24.41. Profit margin for the company is 3.69%. Distance from 52-week low is 89.89% and -1.51% from its 52-week high. The company has generated returns on investments over the last 12 months (2.20%).
The EPS is expected to grow by 28.42% this year
600.0 institutions hold shares in Globus Medical Inc (GMED), with institutional investors hold 82.56% of the company’s shares. The shares outstanding are 113.91M, and float is at 112.91M with Short Float at 2.53%. Institutions hold 82.05% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 10.67 million shares valued at $731.06 million. The investor’s holdings represent 7.8857 of the GMED Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 10.34 million shares valued at $708.18 million to account for 7.6389 of the shares outstanding. The other top investors are JANUS HENDERSON GROUP PLC which holds 7.38 million shares representing 5.4558 and valued at over $505.79 million, while STATE STREET CORP holds 2.5779 of the shares totaling 3.49 million with a market value of $238.99 million.
Globus Medical Inc (GMED) Insider Activity
The most recent transaction is an insider sale by Scavilla Daniel T, the company’s President, CEO. SEC filings show that Scavilla Daniel T sold 60,000 shares of the company’s common stock on Nov 06 ’24 at a price of $80.02 per share for a total of $4.8 million. Following the sale, the insider now owns 0.0 shares.
Globus Medical Inc disclosed in a document filed with the SEC on Nov 06 ’24 that Huller Kelly (SVP, GC, Corporate Secretary) sold a total of 5,000 shares of the company’s common stock. The trade occurred on Nov 06 ’24 and was made at $81.01 per share for $0.41 million. Following the transaction, the insider now directly holds 0.0 shares of the GMED stock.
Still, SEC filings show that on Nov 06 ’24, Scavilla Daniel T (Officer) Proposed Sale 60,000 shares at an average price of $79.97 for $4.8 million. The insider now directly holds shares of Globus Medical Inc (GMED).
